Emergent BioSolutions Inc. (EBS)
Market Closed
16 Oct, 08:00 PM
$
6. 38
-0.8
-11.1421%
$
327.12M Market Cap
- P/E Ratio
7.42% Div Yield
2.24M Volume
-4.4 Eps
$ 7.18
Previous Close 
Want to track EBS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Emergent BioSolutions Inc. (EBS) Statistics
Valuation metrics
Market Cap 327.12M
Enterprise value 769.22M
Trailing P/E (ttm) -1.85
Forward P/E 2.68
PEG ratio -0.1
Price/Sales (ttm) 0.42
Price/Book (mrq) 0.96
Enterprise Value/Revenue 1
Enterprise Value/EBITDA -1,098.89
Overview
Shares outstanding 52.1M
Float 47.11M
Shares short 9.65M
% Held by insiders 0.02%
% Held by institutions 0.82%
Average volume (10 days) 1.05M
Average volume (90 days) 1.18M
Price summary
52-Week low 4.36
52-Week high 14.06
Beta 2.36
50-Day moving average 6.58
200-Day moving average 7.41
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.23%
Operating margin -0.07%
Operational effectiveness
Return on assets -0.16%
Return on equity -0.36%
Income Statement
Revenue (ttm) 742.9M
Revenue per share (ttm) 14.93
Quarterly revenue growth (yoy) -0.24%
Gross profit (ttm) 367.3M
EBITDA 262.3M
Net income to common (ttm) 52.6M
Diluted EPS (ttm) -3.43
Quarterly earnings growth (yoy) -0.24%
Balance Sheet
Total cash (mrq) 205.4M
Total cash per share (mrq) 2.71
Total debt (mrq) 583.7M
Total Debt/Equity (mrq) 1.7
Current ratio (mrq) 5.42%
Book value per share (mrq) 6.62
Cash Flow
Cash flow statement 170.6M
Levered free cash flow (LFCF) 205.39M
2026 © Marketlog. All Rights Reserved.
